Perrigo Co PLC (NYSE:PRGO) Q2 2025 Earnings Miss Estimates, Shares Drop 6% in Pre-Market Trading

Last update: Aug 6, 2025

Perrigo Co PLC (NYSE:PRGO) reported its second-quarter 2025 financial results, missing analyst expectations on both revenue and earnings per share (EPS). The market reaction was immediately negative, with shares dropping over 6% in pre-market trading, reflecting investor disappointment.

Key Financial Results vs. Estimates

Revenue: Reported $1.056 billion, falling short of the consensus estimate of $1.104 billion.
EPS: Came in at $0.57, below the expected $0.605.
Full-Year Estimates: Analysts project revenue of $4.52 billion and EPS of $3.10 for 2025.
Q3 Outlook: Revenue is forecasted at $1.14 billion with EPS of $0.81.

The miss on both top and bottom lines suggests challenges in either demand, pricing, or operational efficiency. The pre-market decline indicates that investors were anticipating stronger performance, particularly as Perrigo has been executing its "Three-S" plan (Stabilize, Streamline, and Strengthen).

Press Release Highlights

Perrigo emphasized progress in its strategic initiatives, including:

Divestment Plans: The recently announced sale of its Dermacosmetics business, part of efforts to streamline operations.
Global Growth Model: Scaling its international self-care business, particularly in Europe and Australia.
Brand-Building: Upgraded marketing capabilities, with key brands like Compeed, Mederma, and Nasonex driving performance.

Despite these efforts, the weaker-than-expected Q2 results overshadowed the company’s strategic advancements.

Market Reaction & Performance Trends

The immediate sell-off aligns with broader underperformance over recent periods:

Pre-Market: -6.1%
Last Month: -1.9%
Last Two Weeks: -3.4%

The sustained downward pressure suggests lingering skepticism among investors, possibly due to concerns over execution or competitive pressures in the consumer self-care sector.

Looking Ahead

Perrigo did not provide explicit guidance in its press release, leaving analysts’ estimates as the primary benchmark. The company’s ability to meet or exceed Q3 projections will be critical in rebuilding investor confidence.

For a deeper dive into Perrigo’s earnings and future estimates, visit the earnings estimates page.

Disclaimer: This article is for informational purposes only and does not constitute investment advice.